OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION Trademark

Trademark Overview


On Tuesday, May 25, 2021, a trademark application was filed for OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION with the United States Patent and Trademark Office. The USPTO has given the OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION trademark a serial number of 90733729. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, October 7, 2024. This trademark is owned by Novartis AG. The OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing health information
omb kesimpta (ofatumumab) 20 mg injection

General Information


Serial Number90733729
Word MarkOMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
Filing DateTuesday, May 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, October 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 16, 2022

Trademark Statements


Description of MarkThe mark is a sound and motion mark, namely, an animated sequence, accompanied by the sound of a B Major chord lasting 3.5 seconds, beginning with the stylized letters "OMB", displayed at a forty-five degree tilt, with the "O" in coral and the combined letters "MB" in teal followed by the word "KESIMPTA" in a stylized brown font formed by the appearance of the letters "SIMP" in the middle with the letters "KE" descending from the top left and the letters "TA" rising from the bottom right, followed by a pulse of light effect, followed by the gradual appearance of the brown words "(OFATUMUMAB) 20 MG INJECTION" at the conclusion of the chord and concluding with the full mark. The color white is not claimed as a feature of the mark and appears as background only.
Indication of Colors claimedThe color(s) coral, teal and brown is/are claimed as a feature of the mark.
Translation of Words in MarkThe wording "KESIMPTA" has no meaning in a foreign language.
Goods and ServicesProviding health information
NOT AVAILABLE"OMB", "OFATUMUMAB", AND "20 MG INJECTION"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 20, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4002
CH

Trademark Events


Event DateEvent Description
Thursday, March 3, 2022ASSIGNED TO EXAMINER
Friday, May 28, 2021NEW APPLICATION ENTERED
Friday, August 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 21, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 7, 2022ASSIGNED TO EXAMINER
Tuesday, February 8, 2022ASSIGNED TO EXAMINER
Wednesday, July 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 14, 2022NON-FINAL ACTION E-MAILED
Monday, March 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 14, 2022NON-FINAL ACTION WRITTEN
Tuesday, July 12, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 12, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, July 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 12, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, July 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 16, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 16, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 10, 2023SOU EXTENSION 1 FILED
Wednesday, April 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 2, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 2, 2023SOU EXTENSION 2 FILED
Monday, October 2, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 30, 2024SOU EXTENSION 3 GRANTED
Monday, October 7, 2024SOU EXTENSION 4 FILED
Monday, October 7, 2024SOU EXTENSION 4 GRANTED
Tuesday, April 8, 2025SOU TEAS EXTENSION RECEIVED
Monday, October 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 30, 2024SOU EXTENSION 3 FILED
Saturday, March 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024SOU TEAS EXTENSION RECEIVED